HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats
Titel:
HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats
Auteur:
Shi, Q.J. Wang, H. Liu, Z.X. Fang, S.H. Song, X.M. Lu, Y.B. Zhang, W.P. Sa, X.Y. Ying, H.Z. Wei, E.Q.